Neuberger Berman Group LLC - CEREVEL THERAPEUTICS HLDNG I ownership

Back to all holdings Add to watchlist

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2023$2,572,193
+200.7%
80,912
+130.7%
0.00%
+100.0%
Q1 2023$855,431
-62.1%
35,073
-50.9%
0.00%
-50.0%
Q4 2022$2,254,858–71,492–0.00%–
 Download
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q3 2023
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders